Post on 25-Nov-2018
transcript
For
addi
tion
al in
form
atio
n or
to r
egis
ter
onlin
e, c
onta
ct:
htt
ps:
//cc
ehs.
up
mc.
com
F e b r u a r y 1 3 – 1 5 , 2 0 1 6
Eleventh International Symposium on
Regional Cancer TherapiesSheraton Wild Horse Pass Resort & Spa
Chandler, Arizona
Sponsored by
David C. Koch
Regional Cancer Therapy Center
and
University of Pittsburgh School of Medicine
Center for Continuing Education
in the Health Sciences
and
UPMC Cancer Centers
In Collaboration with
The University of Maryland
Marlene and Stewart Greenebaum
Cancer Center
and
The Medical College of Wisconsin
Cancer Center
Course Co-Directors
H. Richard Alexander, MD
Professor of Surgery
University of Maryland Medical Center
Baltimore, Maryland
David L. Bartlett, MD
Professor of Surgery
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Robert P. Edwards, MD
Professor, Obstetrics and Gynecology and
Reproductive Services
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
T. Clark Gamblin, MD, MS
Stuart D. Wilson Chair in Surgical Oncology
Chief, Division of Surgical Oncology
Associate Professor of Surgery
Medical College of Wisconsin
Milwaukee, WisconsinDavid
C. K
och
Regi
onal
Canc
er T
hera
py C
ente
r
UPM
C Ca
ncer
Pav
ilion,
Sui
te 4
13
5150
Cen
tre A
venu
e
Pitts
burg
h, P
A 15
232
Nonp
rofit
Org
.U.
S. P
osta
gePA
IDPi
ttsbu
rgh,
PA
Perm
it No
. 383
4
Ele
ven
th I
nte
rnat
ion
al S
ympo
siu
m o
n
Reg
ion
al C
ance
r T
hera
pies
Sher
aton
Wil
d H
orse
Pas
s R
esor
t &
Spa
– C
han
dler
, Ari
zon
a
Fe
br
ua
ry
13
–1
5,
20
16
~ 2 ~ ~ 3 ~
Intent and Overview
This course is designed to cover the most recent advances in cancer therapy that are
primarily of a regional focus, such as gastrointestinal, intraperitoneal, hepatic, ovarian
and thoracic. Upon completion of the activity, learners from several disciplines should
be able to discuss the latest regional therapies in surgical oncology.
Who Should Attend
This course is designed for physicians and nurses practicing in the areas of Medical,
Surgical, Thoracic and Gynecologic Oncology and Gastroenterology.
Continuing Education Credit
The University of Pittsburgh School of Medicine is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical education
for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a
maximum of 20.75 AMA PRA Category 1 Credits™. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
Other health care professionals are awarded 2.0 continuing education units (CEU’s)
which are equal to 20.7 contact hours.
Special Needs
Participation by all individuals is encouraged. Advance notification of any special needs
will help us provide better service. Please notify us of your needs at least two weeks in
advance of the program by calling Maureen Hewko at (412) 623-5993.
We Gratefully Acknowledge Support from:
Magee-Womens Research Institute & Foundation
Schedule – Saturday, February 13, 2016
6:30 am Registration and Breakfast
6:45 am Welcome
Moderators: Steven Ahrendt, MD and Guillermo Flores Ayala, MD
7:00 am The Comprehensive Complication Index: A New Measure
of the Burden of Complications after HIPEC
Sinziana Dumitra, MD, et. al.
7:15 am Re-admissions for Delayed Complications after CRS and HIPEC
Vassiliki Manou, MD, et. al.
7:30 am Goal-Directed Fluid Management Improves Morbidity Associated with
Extended Cytoreduction and HIPEC
Laura Lambert, MD, et. al.
7:45 am Repeat CRS and HIPEC for the Treatment of Recurrent Peritoneal Surface
Malignancy: Is it Worthwhile?
Ramy Fouad, MD, et. al.
8:00 am Delayed Gastric Emptying following CRS and HIPEC
Lola Chabtini, MD, et. al.
8:15 am Acute Kidney Injury in Patients Undergoing CRS plus HIPEC
George Salti, MD, et. al.
8:30 am Impact of Previous Gynecologic Surgical Procedures on Short Term and
Oncological Outcomes in Patients Treated with CRS and HIPEC
Marcello Guaglio, MD, et. al.
8:45 am Is Diverting Ostomy Needed in High-Risk Anastomosis During
Cytoreductive Surgery and HIPEC?
Matthew Whealon, MD, et. al.
9:00 am Impact of Chemotherapy Regimen on Post-Operative Complications
After CRS and HIPEC
Juan Camilo Correa, MD, et. al.
9:15 am Debate: Repeat CRS/HIPEC for Patients Who Recur within Two Years?
Moderator: John Kane III, MD
YES — Kiran Turaga, MD NO — Konstantinos Votanopoulos, MD
9:45 am Break
~ 4 ~ ~ 5 ~
Moderators: T. Clark Gamblin, MD, MS and James Cusack, MD
10:00 am Does Fellowship Training Overcome the Learning Curve in Cytoreductive
Surgery and Heated Intraperitoneal Chemoperfusion
Cameron Schlegel, MD, et. al.
10:15 am Defining Selection Criteria for Patients with Advanced Peritoneal Carcinomatosis of Colorectal Origin
C. Komen Brown, MD, et. al.
10:30 am Impact of Body Mass Index (BMI) on Morbidity and Mortality in
Cytoreductive Surgery (CRS) with Intraperitoneal Chemotherapy (IPC)
Giorgos Karakousis, MD, et. al.
10:45 am Hepatic Artery Infusion for Recurrent or Chemo Resistant
Hepatic Malignancy
Harold Wanebo, MD, et. al.
11:00 am Novel Mouse Models of Hepatic Artery Infusion (HAI)
Minhyung Kim, MD, et. al.
11:15 am Overall Survival after Ablation for Small Size Hepatocellular Carcinoma
at Academic Cancer Centers vs. Community Cancer Centers
Nicholas Berger, MD, et. al.
11:30 am Ablation for Small HCC Lesions: Is Chemotherapy Necessary?
Nicholas Berger, MD, et. al.
11:45 am Liver Resection Following Selective Internal Radiation Treatment with
Yttrium-90: A Bi-Institutional Analysis
G. Paul Wright, MD, et. al.
Noon GUEST LECTURER
Hepatic Artery Infusional Chemotherapy for Primary and
Metastatic Cancer
Michael D’Angelica, MD, FACS
12:30 pm Break for Lunch
12:45 pm CASE PRESENTATION AND DISCUSSION
Discussants: H. Richard Alexander, MD and Nathan Bahary, MD
Immunotherapy for Peritoneal Carcinomatosis
Nathan Bahary, MD
Hepatoid Carcinoma of the Ovary with Peritoneal Metastases Treated
with Cytoreductive Surgery and HIPEC
Samer Naffouje, MD, et. al.
Unusual Presentation of Pseudomyxoma Peritonei
Amy Schulze, MD, et. al.
Intrauterine Metastases of Appendiceal Tumors Impact Cytoreduction
Jessica Cintolo-Gonzalez, MD, et. al.
Cytoreductive Surgery and HIPEC for Sarcomatosis from Uterine
Adenosarcoma
Michael O’Leary, MD, et. al.
Peritoneal Recurrent Fibrolamellar Hepatocullar Carcinoma Treated
with CRS and HIPEC
David Brown, MD, et. al.
1:45 pm Saturday Session Adjournment
6:00 pm Poster Sessions
7:00 pm MEET THE PROFESSOR RECEPTION
Presentation of Gabriella Graham Patient Advocate Award
by Laura Lambert, MD
Schedule – Sunday, February 14, 2016 6:30 am Registration and Breakfast 6:45 am Welcome
Moderators: Jason Foster, MD and Matthew Holtzman, MD
7:00 am Recurrence of Malignant Peritoneal Mesothelioma:
Insights Based on Standardized Second Look Procedures
Michael Kluger, MD, et. al.
~ 6 ~ ~ 7 ~
7:15 am Peritoneal Surface Oncology Group International Registry on Peritoneal Mesothelioma
Marcello Deraco, MD, et. al. 7:30 am Outcomes of Well-Differentiated Papillary Peritoneal Mesothelioma Garrett Nash, MD, et. al. 7:45 am Nomogram to Predict Overall Survival in Diffuse Malignant Peritoneal
Mesothelioma: A Peritoneal Surface Oncology Group International (PSOGI) Multicenter Study
Shigeki Kusamura, MD, et. al. 8:00 am Long-term Combined Intraperitoneal and Systemic Chemotherapy for
Patients with Malignant Mesothelioma Results in Improved Survival Paul Sugarbaker, MD, et. al. 8:15 am Dual Cavity Malignant Mesothelioma: Presentation and Survival Yaakov Bressler, MD, et. al. 8:30 am Analysis of Outcomes in Young Patients (≤ 50 y) with Malignant
Peritoneal Mesothelioma Treated with Cytoreductive Surgery and HIPEC Julie Terhune, MD, et. al.
8:45 am Predicting Risk of Peritoneal Recurrence in Stage II Colon Cancer: Secondary Analysis of CALGB9581 Trial
Rahul Rajeev, MD, et. al. 9:00 am Multimodality Therapy for Peritoneal Metastases from Epithelial
Ovarian Cancer Deepa Magge, MD, et. al.
9:15 am GUEST LECTURER
Scientific Basis for CRS and HIPEC in the Treatment of Peritoneal Metastases: A Historical Perspective
Paul Sugarbaker, MD
9:45 am Break/Exhibitors/Posters Moderators: Robert Edwards, MD and Marcello Deraco, MD
10:00 am Perioperative Systemic Chemotherapy for Peritoneal Mucinous
Appendiceal Carcinomas Treated with Cytoreductive Surgery and HIPEC
John Spiliotis, MD, et. al.
10:15 am Multi-institution Review of the Role of Cytoreductive Surgery
and Heated Intraperitoneal Chemotherapy in Metastatic Gastric
Adenocarcinoma in the U.S.
Laura Enomoto, MD, et. al.
10:30 am Management of Peritoneal Carcinomatosis of a Colonic Origin: Role of
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy:
A Single Institution’s Experience over Two Decades
Chukwuemeka Ihemelandu, MD, et. al.
10:45 am Cytoreductive Surgery and HIPEC: Can We Improve Survival with Less
Postoperative Complications?
Mecker Moller, MD, et. al.
11:00 am Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases
Combined with Curative Surgery for Hematogenous Metastases:
Analysis of Early and Long-Term Outcomes
Dario Baratti, MD, et. al.
11:15 am Peritonectomy Procedures Combined with HIPEC in Advanced Ovarian
Cancer Retrospective Italian National Multicenter Observational Study:
Update of 503 Cases
Paolo Sammartino, MD, et. al.
11:30 am Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors
with Peritoneal Dissemination After HIPEC
Joel Baumgartner, MD, et. al.
11:45 am Cytoreductive Surgery and HIPEC in the Management of Uterine
Sarcoma (US) with Peritoneal Dissemination (PD)
Armando Sardi, MD, et. al.
Noon GUEST LECTURER
New Advances in the Immunotherapy of Ovarian Cancer
Adekunle Odunsi, MD, PhD
12:30 pm Lunch
~ 8 ~ ~ 9 ~
1:00 pm PROPOSED AND ONGOING CLINICAL TRIALS
Discussants: Charles Staley, MD and Jesus Esquivel, MD
Assessment of Pre-Operative PCI Scoring with Integrated PET-DWI-MRI in Patients with Peritoneal Carcinomatosis: A Feasibility Pilot Study in Development
Daniel Labow, MD, et. al.
A Minimally Invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy
Kaitlyn Kelly, MD, et. al.
A Phase I Clinical Trial of Bi-Directional Chemotherapy for Unresectable Appendiceal or Colon Cancer
Bradley Switzer, MD, et. al.
A Phase II Study to Evaluate Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma with Peritoneal Carcinomatosis
Joel Baumgartner, MD, et. al.
The Role of Second-Look Laparoscopy in Patients at Risk of Recurrent Peritoneal Carcinomatosis
Yahel Agmon, MD, et. al.
Phase I/II Trial Evaluating aDCI Vaccines Combined with Tumor-selective Chemokine Modulation as Adjuvant Therapy after Surgical Resection of Peritoneal Surface Malignancies
Mark Girgis, MD
Update on ICARUS: A Randomized Trial of Intraperitoneal Chemotherapy After CRS for Appendiceal or Colorectal Carcinoma
Garrett Nash, MD
Prospective Randomized Trial Comparing Mitomycin and Oxaliplatinum in the Perfusate of Patients Undergoing HIPEC for Cancer of Appendix
Edward Levine, MD
2:00 pm Sunday Session Adjournment 6:00 pm Poster Viewing 7:00 pm ASPSM Meeting Schedule – Monday, February 15, 2016 6:30 am Registration and Breakfast 6:45 am Welcome
Moderators: Jonathan Zager, MD and Douglas Tyler, MD
7:00 am Pulmonary Suffusion for Oligometastatic Malignancies Todd Demmy, MD, et. al. 7:15 am BrachyVAC Treatment of Superficial Malignancies: Results of a
Consecutive Case Series Mark Goodman, MD, et. al. 7:30 am Clinical Response and Regional Toxicity Following Isolated Limb Infusion
Compared to Isolated Limb Perfusion for In-Transit Melanoma Metastases Lesly Dossett, MD, et. al. 7:45 am Electrochemotherapy in Locally Advanced Melanoma and Non-
Melanoma Skin Cancer: Experience from a Single Institution Alessandro Testori, MD, et. al. 8:00 am Inflammation-based Prognostic Scores; Utility in Prognostication and
Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with PC of a Colonic Origin
Chukwumeka Ihemelandu, MD, et. al. 8:15 am Aminolevulinic acid (ALA) is a Promising Compound for Detection of
Small Peritoneal Metastases: ALA Guided Cytoreductive Surgery Yutaka Yonemura, MD, et. al. 8:30 am A Comparison of Appendectomy Only vs. Cytoreductive Surgery and
HIPEC in 59 Patients with Early Stage Mucinous Appendiceal Neoplasms Jesus Esquivel, MD 8:45 am A Comprehensive Evaluation of Barriers to Referral of Patients for
Cytoreductive/HIPEC Valerie Francescutti, MD, et. al. 9:00 am A Snapshot of CS/HIPEC Perioperative Care Practice Patterns Around
the World: On the Pathway to Success or Opportunity for Improvement Allison Maciver, MD, et. al. 9:15 am Prognostic Factors and Significance of Gastrointestinal Leak
after Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC)
Konstantinos Chouliaras, MD, et. al. 9:30 am GUEST LECTURER
The Genetics of Peritoneal Surface Malignancies: Insights and Opportunities
Andrew Lowy, MD
10:00 am Break/Exhibitors/Posters
~ 10 ~ ~ 11 ~
Moderators: James Pingpank, MD and Brian Loggie, MD
10:15 am Multimodality Approach to Peritoneal Metastases: 1312 Patients Treated by a Multi-Disciplinary Team
Haroon Choudry, MD, et. al. 10:30 am Molecular Profiling: Prognostic Biomarkers in Patients Presenting with
Peritoneal Carcinomatosis of the Appendix and Colon Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Chukwuemeka Ihemelanda, MD, et. al. 10:45 am Single-Port Access for Pressurized Intra-Peritoneal Aerosol
Chemotherapy (PIPAC): Feasibility and Safety Michele DeSimone, MD, et. al. 11:00 am MDM-2 Overexpression in Human Stem-like and Mature Colon
Cancer Cells as a Target for Anti-Cancer Therapy: Steps Toward a Translational Model
Mohammad Shaikh, MD, et. al. 11:15 am The Use of a pH-activated Indocyanine Green-Encoded Nanosensor
(PINS) for Detection of Peritoneal Disease Glen Balch, MD, et. al. 11:30 am Evaluation of Glycoprotein Expression Profiles in Peritoneal Metastases Asish Patel, MD, et. al. 11:45 am Exploration of Mutations in GI Cancers with Peritoneal Metastasis Asish Patel, MD, et. al. Noon Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System
for Cytoreductive Surgery Carlos HF Chan, MD, et. al. 12:15 pm Molecular Profiling of Appendix-Derived Pseudomyoxoma Peritonei (PMP) Elizabeth Gleeson, MD, et. al. 12:30 pm Analysis of Twenty Years of Reporting on Hyperthermic Intraperitoneal
Chemotherapy for Colorectal Cancers: Proposal for Standardized Reporting Samer Naffouje, MD, et. al. 12:45 pm Break for Lunch
12:55 pm Announcement and Presentation of Poster Award Winners 1:00 pm Conference Adjournment
Poster Presentations
1. The Effect of Perfusate Buffering on Toxicity and Response in Isolated Hepatic
Perfusion for Uveal Melanoma Metastases – Ilan Ben-Shabat, MD, et. al.
2. The Potential Impact of Host Murine Granulocytes on Growth of Human
Appendiceal Cancer – Laura Lambert, MD, et. al.
3. Expression of Adhesion Molecules in Peritoneal Carcinomatosis from Colon
Cancer: Identification of New Prognostic Factors – Simone Sibio, MD, et. al.
4. A Novel Approach to Diaphragm Resection in Cytoreductive Surgery – Cameron
Schlegel, MD, et. al.
5. A Phase II Randomized Study: Outcomes after Cytoreductive Surgery (CRS) with or
without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) followed
by Adjuvant Chemotherapy as Initial Treatment – Armando Sardi, MD, et. al.
6. BRAF Status as a Predictive Factor for Response in Isolated Limb Perfusion – Ilan
Ben-Shabat, MD, et. al.
7. Intensive Care Unit Hospitalization after Cytoreductive Surgery and Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) – John Spiliotis, MD, et. al.
8. Creating a Primary Regional Referral Center for Cytoreductive Surgery and Hyper
thermic Intraperitoneal Chemotherapy (CRS/HIPEC) – Ea-sle Chang, MD, et. al.
9. CEA Level Predicts Oncologic Outcomes Following Surgical Resection of Colorectal
Peritoneal Metastases – G. Paul Wright, MD, et. al.
10. Does Upfront Therapy with Cytoreductive Surgery and HIPEC Confer a Survival
Benefit in Patients with Synchronous Gastric Peritoneal Carcinomatosis when
Compared with Patients with Metachronous Gastric Peritoneal Carcinomatosis. –
Nikolaos Kopanakis, MD, et. al.
11. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Provides a
Survival Benefit in Unresectable Peritoneal Carcinomatosis – Mecker Moller, MD, et. al.
12. Perioperative Hyperglycemia in Patients Undergoing Cytoreductive Surgery and
HIPEC – Julie Campbell, MD, et. al.
13. Water Lavage during Cytoreductive Surgery with Hyperthermic Intraperitoneal
Chemotherapy (CRS – HIPEC) – Emmanuel Gabriel, MD, et. al.
~ 12 ~ ~ 13 ~
14. An Investigation of Factors Necessitating Abortion of Cytoreduction and HIPEC in a
Newly Established Center for Peritoneal Malignancy – Whitney Guerrero, MD, et. al.
15. Impact of KRAS/BRAF Mutations in Patients with Colorectal Peritoneal
Metastases G. Paul Wright, MD, et. al.
16. Does Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Lead
to Worse Quality of Life? – Gregory Tiesi, MD, et. al.
17. Predictors of Palliative Care Consultation in Patients Undergoing Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) – Rachel Morris, MD, et. al.
18. Trends in Utilization of CRS and HIPEC for Peritoneal Malignancies –
Kazi Ullah, MD, et. al.
19. Clinicopathological Features of Appendix Mucocele: Are We Too Aggressive? –
William Morano, MD, et. al.
20. Let’s Agree to Agree: Unification of Practice Among HighVolume CS/HIPEC
Surgeons in the United States – Eisar Al-Sukhni, MD, et. al.
21. Regional Therapy for Isolated Peritoneal Metastases from Small Bowel
and Upper Gastrointestinal Malignancies – Deepa Magge, MD, et. al.
22. Same Day Extubation After Cytoreductive Surgery and HIPEC –
Hatem Halabi, MD, et. al.
Course Co-Directors
H. Richard Alexander, MDProfessor of Surgery
University of Maryland School of Medicine
Baltimore, MD
David L. Bartlett, MDProfessor of Surgery
University of Pittsburgh School of Medicine
Robert P. Edwards, MDProfessor, Obstetrics, Gynecology and
Reproductive Sciences
University of Pittsburgh School of Medicine
T. Clark Gamblin, MD, MSStuart D. Wilson Chair in Surgical Oncology
Chief, Division of Surgical Oncology
Associate Professor of Surgery
Medical College of Wisconsin
Milwaukee, WI
Guest Faculty
Michael D’Angelica, MD, FACSEnid A. Haupt Chair in Surgery, Memorial
Sloan Kettering Cancer Center
Attending Surgeon, Hepatopancreatobiliary
Service, Memorial Sloan Kettering
Cancer Center
Program Director, Complex Surgical
Oncology and HPB Fellowship
Professor of Surgery, Cornell University,
Weill Medical College
New York, NY
Andrew Lowy, MDProfessor of Surgery
UC San Diego Medical Center
School of Medicine
La Jolla, CA
Adekunle Odunsi, MD, PhDCancer Center Deputy Director
The M. Steven Piver Professor and Chair
Department of Gynecologic Oncology
Executive Director, Center for
Immunotherapy
Roswell Park Cancer Institute
New York, NY
Paul H. Sugarbaker, MDDirector, Program in Peritoneal Surface
Malignancy
Washington Hospital Centre
Washington, DC
Invited Faculty
Steven Ahrendt, MDAssociate Professor of Surgery
University of Pittsburgh School of Medicine
Guillermo Flores Ayala, MD Instituto Jaliscience de Cancerologia
Guadalajara, Mexico
Nathan Bahary, MDAssociate Professor of Medicine
University of Pittsburgh School of Medicine
Glen Balch, MDAssistant Professor of Surgery
University of Texas
Dallas, TX
Joel Baumgartner, MDUCSD Moores Cancer Center
La Jolla, CA
C. Komen Brown, MDCancer Treatment Centers of America
Zion, IL
Haroon Choudry, MDAssistant Professor of Surgery
University of Pittsburgh School of Medicine
~ 14 ~ ~ 15 ~
James Cusack, MDAssociate Professor of Surgery
Harvard Medical School
Boston, MA
Marcello Deraco, MDSurgical Oncologist
Foundazione IRCCS Instituto
Nazionale dei Tumori
Milano, Italy
Jesus Esquivel, MDMedical Director, International
Oncology Initiatives
CTCA
Philadelphia, PA
Jason Foster, MDAssociate Professor of Surgery
Nebraska Medical Center
Omaha, NE
Matthew Holtzman, MDAssociate Professor of Surgery
University of Pittsburgh School of Medicine
John Kane III, MDAssociate Professor of Oncology
Roswell Park Cancer Institute
Associate Professor of Surgery
University of Buffalo
Buffalo, NY
Daniel Labow, MDThe Mount Sinai Medical Center
New York, NY
Laura Lambert, MDUniversity of Massachusetts
Medical School
Worcester, MA
Edward Levine, MDProfessor of Surgery
Wake Forest University
WinstonSalem, NC
Brian Loggie, MDProfessor of Surgery
Creighton University Medical Center
Omaha, NE
Garrett Nash, MDMemorial Sloan Kettering Cancer Center
New York, NY
James Pingpank, MDAssociate Professor of Surgery
University of Pittsburgh School of Medicine
Charles Staley, MDProfessor of Surgery
Emory University
Atlanta, GA
Kiran Turaga, MDAssistant Professor of Surgery
Medical College of Wisconsin
Milwaukee, WI
Douglas S. Tyler, MDProfessor of Surgery
Duke University
Durham, NC
Konstantinos Votanopoulos, MDAssociate Professor of Surgery
Wake Forest University
WinstonSalem, NC
Jonathan Zager, MDAssociate Professor of Surgery
Moffitt Cancer Center
Tampa, FL
All individuals in a position to control the content of this education activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
Faculty reside in the Pittsburgh, Pennsylvania, metropolitan area unless indicated otherwise.
The University of Pittsburgh is an affirmative action, equal opportunity institution.
Abstract/Poster Presenters
Yahel Agmon, MDThe Mount Sinai Medical Center
New York, NY
Eisar Al-Sukhni, MDRoswell Park Cancer Institute
Buffalo, NY
Dario Baratti, MDInstituto Nazionale Tumori
Milano, Italy
Ilan Ben-Shabat, MDSahlgrenska University Hospital
Gothenburg, Sweden
Nicholas Berger, MDMedical College of Wisconsin
Milwaukee, WI
Yaakov Bressler, MDColumbia University Medical Center
New York, NY
David Brown, MDSwedish Cancer Institutte
Seattle, WA
Julie Campbell, MDPenn State Hershey College of Medicine
Hershey, PA
Lola Chabtini, MDIndiana University Department of Surgery
Indianapolis, IN
Carlos HF Chan, MDMassachusetts General Hospital
Boston, MA
Ea-sle Chang, MDSt. Louis University Hospital
St. Louis, MO
Konstantinos Chouliaras, MDWake Forest Baptist Health
WinstonSalem, NC
Jessica Cintolo-Gonzalez, MDMassachusetts General Hospital
Boston, MA
Juan Camilo Correa, MDUniversity of Toronto
Toronto, Canada
Todd Demmy, MDRutgers Cancer Institute of New Jersey
New Brunswick, NJ
Michele DeSimone, MDFoundazione IRCCS InstitutoNazionale
dei Tumori
Milano, Italy
Lesly Dossett, MDH. Lee Moffitt Cancer Center and
Research Institute
Tampa, FL
Sinziana Dumitra, MDCity of Hope
Duarte, CA
Laura Enomoto, MDPenn State Hershey Medical Center
Hershey, PA
Ramy Fouad, MDIcahn School of Medicine at
Mount Sinai
New York, NY
Valerie Francescutti, MDRoswell Park Cancer Institute
Buffalo, NY
Emmanuel Gabriel, MDRoswell Park Cancer Institute
Buffalo, NY
Mark Girgis, MDUniversity of Pittsburgh Medical Center
Pittsburgh, PA
~ 16 ~ ~ 17 ~
Elizabeth Gleeson, MDDrexel University College of Medicine
Philadelphia, PA
Mark Goodman, MDUniversity of Pittsburgh Medical Center
Pittsburgh, PA
Marcello Guaglio, MDFoundazione IRCCS Instituto
Nazionale dei Tumori
Milano, Italy
Whitney Guerrero, MDUniversity of Tennessee Health Center
Memphis, TN
Hatem Halabi, MDCancer Treatment Centers of America
Zion, IL
Chukwuemeka Ihemelandu, MDMedStar Washington Hospital Center
Washington, DC
Giorgos Karakousis, MDHospital of the University of Pennsylvania
Philadelphia, PA
Kaitlyn Kelly, MDUniversity of California, San Diego
La Jolla, CA
Minhyung Kim, MDRoswell Park Cancer Institute
Buffalo, NY
Michael Kluger, MDColumbia College of Physicians and
Surgeons
New York, NY
Nikolaos Kopanakis, MDMetaxa Cancer Center
Piraeus, Greece
Shigeki Kusamura, MDMilan Tumor Institute
Milano, Italy
Allison Maciver, MDRoswell Park Cancer Institute
Buffalo, NY
Deepa Magge, MDUniversity of Pittsburgh Medical Center
Pittsburgh, PA
Vasiliki Manou, MDMetaxa Cancer Hospital
Piraeus, Greece
Mecker Moller, MDUniversity of Miani Miller School of
Medicine
Miami, FL
William Morano, MDDrexel University College of Medicine
Philadelphia, PA
Rachel Morris, MDMedical College of Wisconsin
Milwaukee, WI
Samer Naffouje, MDUniversity of Illinois at Chicago
Chicago, IL
Michael O’Leary, MDCity of Hope National Medical Center
Duarte, CA
Asish Patel, MDUniversity of Nebraska Medical Center
Omaha, NE
Rahul Rajeev, MDMedical College of Wisconsin
Milwaukee, WI
George Salti, MDUniversity of Illinois at Chicago and Edward
Cancer Center
Chicago, IL
Paolo Sammartino, MDSapienza University of Rome
Rome, Italy
Armando Sardi, MDMercy Medical Center
Baltimore, MD
Cameron Schlegel, MDVanderbilt University
Nashville, TN
Amy Schulze, MDIndiana University School of Medicine
Indianapolis, IN
Mohammad Shaikh, MDDrexel University College of Medicine
Philadelphia, PA
Simone Sibio, MDUniversity of Rome
Rome, Italy
John Spiliotis, MDMetaxa Cancer Hospital
Piraeus, Greece
Bradley Switzer, MDUniversity of Massachusetts
Worcester, MA
Julie Terhune, MDUniversity of Maryland
Baltimore, MD
Alessandro Testori, MDIstituto Europeo di Oncologia
Milano, Italy
Gregory Tiesi, MDUniversity of Miller School of Medicine
Miami, FL
Kazi Ullah, MDSUNY Stony Brook
Stony Brook, NY
Harold Wanebo, MDRoger Williams Medical Center
Bristol, RI
Matthew Whealon, MDUniversity of California Irvine
Orange, CA
G. Paul Wright, MDUniversity of Pittsburgh Medical Center
Pittsburgh, PA
Yutaka Yonemura, MDKishiwada Tokushukai Hospital
Kyou, Japan
~ 18 ~ ~ 19 ~
Registration Information
Online Registration is accepted until February 12, 2016. After this date, you are only
able to register for the conference on site.
Registering online is the quickest and easiest way to reserve your space at CCEHS
conferences.
Visit our online registration site at https://ccehs.upmc.com. Scroll down to the Eleventh
International Symposium on Regional Cancer Therapies section on the web page.
• Click the registration button and enter all of the requested information.
• After registering, an electronic confirmation will be sent to the email address you
provided when you registered.
Registration is not complete until you receive the confirmation email for your
preregistration. If you do not receive this letter within 57 days of registration, please
contact Maureen Hewko at (412) 623-5993.
You must bring this confirmation with you to the conference.
Registration Cancellation
All cancellations must be in writing and sent to us via US mail, email or fax. Tuition
cancellations postmarked or date stamped before January 13, 2016 will be completely
refunded. After January 13, 2016, a $35 administrative fee will be assessed. No refunds
will be made after February 1, 2016.
Conference contact for cancellation requests:
Maureen Hewko, MBA
UPMC Cancer Pavilion 413, 5150 Centre Avenue
Pittsburgh, PA 15232
Email: hewkom@upmc.edu • Telephone: (412) 6235993
Fax: (412) 6922520
Registration Fees
$350 Physicians and researchers
$250 Nurses and other health care professionals
Registration fee includes:
• Continuing education credit
• Registration and course materials
• Continental breakfast, refreshments and a light lunch
• If interested, workshops on Sunday afternoon.
Meeting Location
The conference will be held at the Sheraton Wild Horse Resort. Conference
reservations are at the sole responsibility of the attendees who may contact the hotel.
If registering for a room at the hotel online, please go to http://www.regionaltherapies.
com and click on conference information.
If you wish to make your reservation by phone, please call 5207968278 and mention
that you are with the UPMC group.
The cutoff date for reserving a room at the discounted rate of $234 per night is
January 13, 2016.
Accommodations
Nightly Guest Room Rate: $234 per night
Note: Resorts room rates are subject to additional taxes and resort fees as applicable.
Transportation
If you are flying to the conference, the closest airport to the Sheraton is the Phoenix
International Airport. Please go to www.regionaltherapies.com for information about
transportation from the airport.
For additional information, contact:
Maureen Hewko, MBATelephone: (412) 6235993Fax: (412) 6922520Email: hewkom@upmc.eduKoch Center Website: http://www.regionaltherapies.com
Visit the Center for Continuing Education in the Health Sciences Web Site
Our Internet address is: https://ccehs.upmc.com
The UPMC Center for Continuing Education in the Health Sciences invites you to visit our web location. Receive information on CME programs, earn CME credits on the Internet, and access information about our formal courses and much more. Discover who we are and how you can contact us. Please visit our web location often to get updated information on upcoming programs.